CURIAN CAPITAL LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,029 filers reported holding BAXTER INTL INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
CURIAN CAPITAL LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2015$8,383,000
-20.4%
119,872
-22.0%
0.14%
-19.9%
Q1 2015$10,528,000
+1.4%
153,695
+8.5%
0.18%0.0%
Q4 2014$10,386,000
+9.9%
141,713
+7.6%
0.18%
+5.4%
Q3 2014$9,452,000
+3.1%
131,704
+3.9%
0.17%
+3.7%
Q2 2014$9,164,000
+0.1%
126,746
+1.9%
0.16%
-1.2%
Q1 2014$9,156,000
+11.9%
124,430
+5.7%
0.16%
+12.4%
Q4 2013$8,184,000
+4.6%
117,669
-1.2%
0.14%
+3.6%
Q3 2013$7,824,000
+4.3%
119,098
+10.0%
0.14%
+2.9%
Q2 2013$7,502,000108,3070.14%
Other shareholders
BAXTER INTL INC shareholders Q4 2014
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders